Severe Hypercalcaemia from Ectopic Intact Parathyroid Hormone Secretion Treated with Continuous Renal Replacement Therapy in a Patient with Two Malignancies

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2021 Jun 30

PMID 34187797

Authors

Nathaniel Hocker

Maria Story

Alysa Lerud

Sarat Kuppachi

Affiliations

Soon will be listed here.

Abstract

We present a 61-year-old Caucasian woman with endometroid carcinoma as well as a poorly differentiated adenocarcinoma who developed severe hypercalcaemia in the setting of an elevated intact parathyroid hormone. The patient was hospitalised twice for her condition. During her first hospitalisation, she was diagnosed with an endometroid carcinoma and hypercalcaemia. With medical management, she had a normal calcium level on discharge. She presented 3 weeks later with hypercalcaemia and encephalopathy. This time her hypercalcaemia was refractory to medical management, and required continuous renal replacement therapy (CRRT) to normalise her serum calcium. Lung biopsy revealed a poorly differentiated adenocarcinoma, suspicious for pancreatic primary. Due to her poor prognosis, rapid elevation of calcium with each attempt to discontinue CRRT, and the poor options for treatment of her cancers, she elected to pursue hospice care.

References

Doyle M, Malcolm J . An unusual case of malignancy-related hypercalcemia. Int J Gen Med. 2013; 7:21-7. PMC: 3862645. DOI: 10.2147/IJGM.S51302. View

VanHouten J, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski J . Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J Clin Endocrinol Metab. 2005; 91(2):580-3. DOI: 10.1210/jc.2005-2095. View

Medas F, Erdas E, Loi G, Podda F, Barca L, Pisano G . Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range. BMC Surg. 2019; 18(Suppl 1):124. PMC: 7402568. DOI: 10.1186/s12893-018-0459-3. View

Kindgen-Milles D, Kram R, Kleinekofort W, Morgera S . Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation. ASAIO J. 2008; 54(4):442-4. DOI: 10.1097/MAT.0b013e31817dc3be. View

Kandil E, Noureldine S, Abdel Khalek M, Daroca P, Friedlander P . Ectopic secretion of parathyroid hormone in a neuroendocrine tumor: a case report and review of the literature. Int J Clin Exp Med. 2011; 4(3):234-40. PMC: 3182517. View

Camus C, Charasse C, Seguin P, Tulzo Y, Bouget J, Thomas R . Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia. Intensive Care Med. 1996; 22(2):116-21. DOI: 10.1007/BF01720717. View

Arps H, Dietel M, Schulz A, Janzarik H, Kloppel G . Pancreatic endocrine carcinoma with ectopic PTH-production and paraneoplastic hypercalcaemia. Virchows Arch A Pathol Anat Histopathol. 1986; 408(5):497-503. DOI: 10.1007/BF00705303. View

Norton K, Johnson L, Griffen F, Burke J, Kennedy S, Aultman D . The sestamibi scan as a preoperative screening tool. Am Surg. 2002; 68(9):812-5. View

Hughes D, Sorensen M, Miller B, Cohen M, Gauger P . The biochemical severity of primary hyperparathyroidism correlates with the localization accuracy of sestamibi and surgeon-performed ultrasound. J Am Coll Surg. 2014; 219(5):1010-9. DOI: 10.1016/j.jamcollsurg.2014.06.020. View

10.

McCauley L, Martin T . Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res. 2012; 27(6):1231-9. PMC: 4871126. DOI: 10.1002/jbmr.1617. View

11.

Stewart A . Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005; 352(4):373-9. DOI: 10.1056/NEJMcp042806. View

12.

Chen L, Dinh T, Haque A . Small cell carcinoma of the ovary with hypercalcemia and ectopic parathyroid hormone production. Arch Pathol Lab Med. 2005; 129(4):531-3. DOI: 10.5858/2005-129-531-SCCOTO. View

13.

Nussbaum S, Gaz R, Arnold A . Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med. 1990; 323(19):1324-8. DOI: 10.1056/NEJM199011083231907. View

14.

Gradwohl-Matis I, Franzen M, Seelmaier C, Brunauer A, Dankl D, Dunser M . Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis. ASAIO J. 2014; 61(2):219-23. DOI: 10.1097/MAT.0000000000000186. View

15.

Kwon H, Kim J, Kim H, Choi Y, Ahn S . Combined Hepatocellular Carcinoma and Neuroendocrine Carcinoma with Ectopic Secretion of Parathyroid Hormone: A Case Report and Review of the Literature. J Pathol Transl Med. 2018; 52(4):232-237. PMC: 6056365. DOI: 10.4132/jptm.2018.05.17. View

16.

Sramek V, Novak I, Matejovic M, Rokyta R, Nalos M, Hora P . Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia. Intensive Care Med. 1998; 24(3):262-4. DOI: 10.1007/s001340050562. View

17.

Wu B, Wang J, Yang G, Xing C, Mao H . Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report. BMC Nephrol. 2018; 19(1):136. PMC: 6000971. DOI: 10.1186/s12882-018-0936-z. View